Patent Assignment
Reel/Frame 055301/0322
Change of Name
Recorded: 2021-02-13
Pages: 2
Assignor
UCB BIOPHARMA SPRL
Executed: 2019-12-02
Assignee
UCB BIOPHARMA SRL
ALLEE DE LA RECHERCHE 60, BRUSSELS, 1070, BELGIUM
Covered Property
(1)
Treatment of Autoimmune Disorders with CD154 Antibodies
Application:
15/547,223 →
Publication:
US 2018/0022812
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.